Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27
Nat Commun
.
2025 May 22;16(1):4769.
doi: 10.1038/s41467-025-60137-1.
Authors
Yong Wang
1
,
Yanan Wang
1
,
Lei Bao
1
,
Goncalo Vale
2
3
,
Jeffrey G McDonald
2
3
,
Yisheng Fang
1
,
Yan Peng
1
,
Ashwani Kumar
4
,
Chao Xing
4
5
,
Fara Brasó-Maristany
6
7
8
,
Aleix Prat
6
7
8
9
10
,
Carlos L Arteaga
11
,
Yingfei Wang
1
11
12
13
,
Weibo Luo
14
15
16
Affiliations
1
Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
2
Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX, USA.
3
Department of Molecular Genetics, UT Southwestern Medical Center, Dallas, TX, USA.
4
Eugene McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX, USA.
5
Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.
6
Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
7
Cancer Institute and Blood Diseases, Hospital Clínic of Barcelona, Barcelona, Spain.
8
Reveal Genomics, S.L., Barcelona, Spain.
9
University of Barcelona, Barcelona, Spain.
10
Institute of Oncology-Hospital Quirónsalud, Barcelona, Spain.
11
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.
12
Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.
13
Peter O'Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA.
14
Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. Weibo.Luo@UTSouthwestern.edu.
15
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. Weibo.Luo@UTSouthwestern.edu.
16
Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA. Weibo.Luo@UTSouthwestern.edu.
PMID:
40404637
PMCID:
PMC12098653
DOI:
10.1038/s41467-025-60137-1
No abstract available
Publication types
Published Erratum